Results 141 to 150 of about 1,113 (191)

Suprachoroidal Delivery of Corticosteroid Slow-Release Implants for the Treatment of Cystoid Macular Edema. [PDF]

Klin Monbl Augenheilkd
Asani B, Siedlecki J, Klaas J, Priglinger SG.   +3 more
europepmc   +1 more source

Recurrent Diabetic Macular Edema: What to Do [PDF]

core   +1 more source

Twelve-Month Outcomes of Faricimab for Patients with Sub-Optimally Responsive Diabetic Macular Oedema: A Retrospective Single-Centre Study. [PDF]

Clin Ophthalmol
El-Badawi K, Scrivens B, Eke O, Ismail R, Kobayter L, Salvatore S.   +5 more
europepmc   +1 more source

Recent Advances in Smart Polymers-Based Therapeutics in Ophthalmology. [PDF]

Int J Nanomedicine
Xie J, Nie L, Pei Y.
europepmc   +1 more source

Beyond the injection: delivery systems reshaping retinal disease management. [PDF]

Expert Opin Pharmacother
Rowe LW, Akotoye C, Harris A, Ciulla TA.
europepmc   +1 more source

Predictive value of short-term steroid intraocular pressure elevation testing for long-term steroid intraocular pressure elevation in diabetic macular edema treatment. [PDF]

Int Ophthalmol
Pestana Aguiar C, Alves Ambrósio J, Miranda V, Ruão M, Duarte L.   +4 more
europepmc   +1 more source

Faricimab for retinal vein occlusion: a review of current evidence and future perspectives. [PDF]

Front Pharmacol
Jing Y, Li D.
europepmc   +1 more source

A Meta-Analysis of the Efficacy and Safety of the 0.19 mg Fluocinolone Acetonide Implant in Non-Infectious Uveitis. [PDF]

Biomedicines
Yeo S, Chung YR, Song JH, Bodaghi B, Touhami S.   +4 more
europepmc   +1 more source

Treatment of diabetic macular edema with ILUVIEN (fluocinolone acetonide 0.19 mg): Pharmacokinetics and lipophilicity for the primary care provider

Journal of Diabetes & Metabolism, 2017
openaire   +1 more source